From biorepositories to data repositories: Open-access resources accelerate early R&D and validation of equitable diagnostic tools.

ABSTRACT: Diagnostics are critical tools that guide clinical decision-making for patient care and support disease surveillance. Despite its importance, developers and manufacturers often note that access to specimen panels and essential reagents is one of the key challenges in developing quality diagnostics, particularly in low-resource settings. A recent example, as the COVID-19 pandemic unfolded there was a need for clinical samples across the globe to support the rapid development of diagnostics. To address these challenges and gaps, PATH, a global nonprofit, along with its partners collaborated to create a COVID-19 biorepository to improve access to biological samples. Since then, the need for data resources to advance universal rapid diagnostic test (RDT) readers and noninvasive clinical measur

SUBMITTER: Peck R 

PROVIDER: S-EPMC10426984 | biostudies-literature | 2023

REPOSITORIES: biostudies-literature